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Abstract
Porous protein cages are supramolecular protein self-assemblies presenting pores that
allow the access of surroundingmolecules and ions into their core in order to store and
transport them in biological environments. Protein cages’ pores are attractive channels for
the internalisation of inorganic nanoparticlesand an alternative for the preparation of hybrid
bioinspired nanoparticles.However, strategies based on nanoparticle transport through the
pores are largely unexplored, due to the difficulty of tailoring nanoparticles that have diame-
ters commensuratewith the pores size and simultaneously displaying specific affinity to the
cages’ core and low non-specific binding to the cages’ outer surface. We evaluated the spe-
cific internalisationof single small gold nanoparticles, 3.9 nm in diameter, into porous pro-
tein cages via affinity binding. The E2 protein cage derived from theGeobacillus
stearothermophilus presents 12 pores, 6 nm in diameter, and an empty core of 13 nm in
diameter. We engineered the E2 protein by site-directed mutagenesis with oligohistidine
sequences exposing them into the cage’s core. Dynamic light scattering and electron
microscopy analysis show that the structures of E2 protein cages mutated with bis- or
penta-histidine sequences are well conserved. The surface of the gold nanoparticleswas
passivated with a self-assembledmonolayer made of a mixture of short peptidols and thio-
lated alkane ethylene glycol ligands. Such monolayers are found to provide thin coatings
preventing non-specific binding to proteins. Further functionalisation of the peptide coated
gold nanoparticleswith Ni2+ nitrilotriaceticmoieties enabled the specific binding to oligohisti-
dine tagged cages. The internalisationvia affinity binding was evaluated by electronmicros-
copy analysis. From the various mutations tested, only the penta-histidinemutated E2
protein cage showed repeatable and stable internalisation.The present work overcomes
the limitations of currently available approaches and provides a new route to design tailored
and well-controlled hybrid nanoparticles.
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Introduction
Protein cages and virus-like particles are highly structured and stable homo- and hetero-supra-
molecular protein self-assemblies.[1] All protein cages share three common structural features:
an external surface, an inner surface or core, and a protein-protein interface. Recent advances
in molecular biology and organic chemistry enable the modification of these features indepen-
dently[2] using genetic mutations, e.g., to replace or introduce amino acid residues at desired
locations, or by bioorthogonal conjugation[3] to add non-native functions, e.g., drugs, bio-
markers or fluorescent dyes.[4] Such flexibility of modificationwith relevant features has
enabled the utilisation of protein cages for a wide range of applications such as bioimaging and
drug delivery.[4–8]
During the last two decades, materials scientists have intensively investigated the manipula-
tion of protein cages for the encapsulation of single inorganic nanoparticles into their core to
design novel hybrid bioinspired nanoparticles.[9,10] As such, the preparation of hybrid nano-
particles has been validated for a variety of inorganic cores, e.g., noble metals[11,12] or metal
oxides,[13] and with different types of protein cages and virus-like particles, e.g., cowpea chlo-
rotic mottle virus[14] or ferritins.[15–20] Interestingly, the development of protein cage-based
hybrid nanoparticles[21] allowed one to combine into the hybrid material the physicochemical
properties of the inorganic nanoparticles, e.g., plasmon resonance, fluorescence, with proper-
ties of biomaterials, e.g., biocompatibility. Therefore, such hybrid nanoparticles represent an
opportunity for advanced nanotechnology applications in the fields of molecular imaging,
[13,16,22] nano-electronics[23] and catalysis.[24,25]
A general concern in the synthesis of protein cage-based hybrid nanoparticles is the ability
to control the interactions at the protein/inorganic nanoparticle interface.[26] Such control is
necessary to achieve specific positioning of inorganic nanoparticles inside the protein cages’
core. Currently, two main approaches are used to synthesise such hybrid biomaterials. The first
strategy uses a process called ‘encapsidation’ that is driven by the reversible self-assembly of a
protein cage. Once disassembled, a mixture of protein subunits is present during the colloidal
suspension of inorganic nanoparticles. Environmental changes, such as pH or temperature, are
then used to trigger the reassembly of the protein cages. The self-assembling of protein cages
occurring around the inorganic nanoparticles is directed by the affinity between the nanoparti-
cles surface and the proteins, e.g., via electrostatic interactions.[17,26–28] The second approach
was inspired by a biological process called ‘biomineralisation.’[14] Biomineralisation is a bio-
chemical reaction occurring in living organisms to isolate, store and transport free ions, that
are otherwise toxic.[29] A typical instance of a protein cage possessing this native biological
function is ferritin. Ferritin is present in most living organisms and contains peptide sequences
that facilitate the oxidation of iron ions and subsequent nucleation and rapid growth of an iron
oxide nanoparticle in the ferritin core.[30] In this approach, the presence of pores in the pro-
tein cage structure is necessary to allow for the passage of surroundingmetal ions into the core.
The unique feature of porous protein cages which allow for the internalisation of materials
via nanometre size pores presents an attractive opportunity also for the internalisation of inor-
ganic nanoparticles. Direct internalisation of nanoparticles inside porous protein cages could
provide an alternative approach for the preparation of hybrid nanoparticles. However, to our
knowledge this strategy remains largely unexplored. Ishii et al. published the first instance of
internalisation of non-coated inorganic nanoparticle, i.e., quantum dots, into preformed tubu-
lar chaperonin proteins GroEL (from Escherichia coli) and T.th (from Thermus thermophilus
HB8).[31] The study demonstrated the use of protein cages to enhance the optical and thermal
stability of quantum dots. Following this research, other studies showed the use of electrostatic
interactions from positively charged residues, e.g., histidine, lysine, to direct the assembly of
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uncoated water-soluble quantum dots to the external surface of protein cages[32,33] or into
their core.[34] Direct internalisation of preformed inorganic nanoparticles is challenged by
some important barriers. The inorganic nanoparticles must be smaller than the protein cage’s
pores to be able to access the core. Such pores are typically up to a few nanometres in diameter.
[1] In addition, non-specific interactions between the inorganic nanoparticles and the proteins
must be also prevented to favour the internalisation of the nanoparticle into the core and to
avoid the adsorption onto protein cages’ outer surface. The surface of the inorganic nanoparti-
cles should therefore include an additional coating that prevents undesired interactions. Anti-
fouling coatings made of long polymers such as polyethylene glycols were shown to be effective
passivating materials and are commonly used in nanomedicine to prevent protein adhesion.
[35] However, such polymer coatings increase significantly the nanoparticles size and hence
limit the nanoparticles access to the protein cage’s core. Finally, the nanoparticles transport
through the protein cage’s pores may be reversible. An additional affinity mechanism between
the inorganic nanoparticle and the protein cage’s core is required to favour the internalisation
process to particle escape.
In this investigation, we evaluate the specific internalisation via affinity binding of single
small gold nanoparticles into porous protein cages. As a porous protein cage, we used the E2
protein cage derived from the Geobacillus stearothermophilus that presents 12 pores of 6 nm
and an empty core of 13 nm in diameter. We engineered the E2 protein by site-directed
mutagenesis with oligohistidine sequences of 4 different repeats exposed in the cages’ core.
Dynamic light scattering and electronmicroscopy analysis confirmedwell-conserved struc-
ture of the E2 protein cages mutated with bis- or penta-histidine sequences. To facilitate the
internalisation, and to prevent non-specific binding of 3.9 nm diameter gold nanoparticles,
their surface was passivated with a self-assembledmonolayer (SAM) made of a mixture of
short peptidols and thiolated alkane ethylene glycol ligands.[36,37] The functionalisation of
the SAM-coated gold nanoparticles with Ni2+ nitrilotriacetic (Ni-NTA) moieties enabled the
specific binding to oligohistidine tagged cages. Finally, the internalisation via affinity binding
of Ni-NTA-functionalised peptide coated gold nanoparticles into the core of E2 protein




The peptidol H-CVVVT-ol was purchased from Peptide and Protein Research (PPR Ltd.,
Hampshire, UK). HS-(CH2)11-EG3-NTA and HS-(CH2)11-EG4 ligands were purchased from
Prochimia (Prochimia Surfaces Sp. z o.o., Sopot, Poland). Gold nanoparticles of 3.9 nm diame-
ter stabilised in citrate buffer were purchased fromNanopartz Inc. (Canada). PBS buffer,
Sephadex G25 superfine resin, dimethylsulfoxide (DMSO), Tween 20, nickel (II) nitrate hexa-
hydrate and sodium phosphotungstate tribasic hydrate were purchased from Sigma-Aldrich
Ltd. (Dorset, UK). Nanosep filters 10 kDa cut-off were purchased from PALL (PALL Corp.,
Portsmouth, Hants, UK). Affi-Gel 10 resin and Tris-HCl were obtained from Bio-Rad Labora-
tories Pte Ltd (Singapore). UV spectra were acquired with a SpectraMax Plus spectrophotome-
ter (Molecular Devices,Wokingham, UK) using a 384 well plates from Corning (Lowell, US).
E. coli strains DH5α (Zymo Research) and BL21(DE3) (Stratagene) were used as host cells. The
vector pET-11a was purchased fromNovagen. The oligonucleotides were synthesised by 1st
BASE (Singapore). Restriction enzymes (BamH I and Nde I), T4 DNA ligase, and Pfu Ultra
High-Fidelity DNA polymerase, and isopropyl β-D-thiogalactopyranoside (IPTG) were
obtained from Fermentas.
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2.2 Preparation of NTA-functionalised peptide coated gold nanoparticles
A 2 mM solution of H-CVVVT-ol was prepared in DMSO:H2OmilliQ 25:75 (v:v). Solutions of
HS-(CH2)11-EG3-NTA and HS-(CH2)11-EG4 (both 2 mM) were prepared in DMSO and etha-
nol respectively. To prepare coated gold nanoparticles, 1 volume of 2 mM solution containing
60% of H-CVVVT-ol, 30% of HS-(CH2)11-EG4 and 10% HS-(CH2)11-EG3-NTA ligand was
mixed with 1 volume of PBS 10X (81 mMNa2HPO4, 12 mMKH2PO4, 1.4 M NaCl, and 27
mMKCl, pH 7.4) and 0.005 volume 1% (v:v) Tween 20 in milliQH2O. Then, 9 volumes of col-
loidal gold solution were added and mixed overnight at room temperature.
2.3 Purificationof NTA-functionalised peptide coated gold nanoparticles
by size exclusion chromatography
Sephadex G25 superfine (10 mL) was prepared, loaded into a column and kept in 0.02% (w:v)
sodium azide. The column was equilibrated with 30 mL of 100 mMNaCl aqueous solution
with 0.002% (v:v) Tween20. Coated gold nanoparticles (1.1 mL) were concentrated to approxi-
mately 150 μL by centrifugation on a 10 kDa cut-off Nanosep filter. Then, nanoparticles were
loaded on the column and eluted under gravity. Approximately 1.4 mL coloured fractions cor-
responding to nanoparticles were collected in the excluded volume.
2.4 Nickel ion loading of NTA-functionalised peptide coated gold
nanoparticles
One-tenth volume of 2.8 M Ni(NO3)2.6H2O aqueous solution was added to 1 volume of puri-
fied coated gold nanoparticles in 100 mMNaCl with 0.005% (v:v) Tween20. The reaction was
mixed overnight at room temperature. The Ni2+ excess, not chelated to the NTA groups, was
removed by size exclusion chromatography on Sephadex G25. The purified nanoparticles were
finally dispersed in PBS pH 8.0 with 0.005% (v:v) Tween 20.
2.5 Preparation of the hexa-histidine resin
Affi-Gel 10 resin slurry (2 mL) was washed with 10mL of cold (4°C) 1 mMHCl, and then twice
with DMSO, to give, 1 mL of resin. To this 950 mL DMSO, and 50 mL H-CVVVTGGGHHH
HHH-OH peptide (5 mM, in DMSO) were added. The reaction was stirred overnight at
room temperature before adding 6 mL 100 mM Tris-HCl, pH 8.5 for 4 h to block unreacted
N-hydroxysuccinimide groups. The resin was washed three times alternately with 50 mM
sodium acetate, 0.5 M NaCl, pH 4.5, and then with 100 mM Tris-HCl, pH 8.5. The resin was
stored at 4°C in 20% (v/v) ethanol/water until further use.
2.6 Design and constructionof E2 protein
Mutant plasmids were generated using site-directedmutagenesis. Oligonucleotides in Table 1
were used to PCR-amplify the mutant plasmid upon pET-11a plasmid containing wild-type E2
gene (pE2-WT).
To construct the expression mutant vectors, the vector pET-11a and the PCR products were
digested with NdeI and BamHI restriction enzymes. Both vector and target E2 genes were puri-
fied by 0.8% (w/v) agarose gel electrophoresis and ligated with T4 ligase. The sequences of the
mutant genes were confirmed by the DNA sequencing service provided by 1st Base.
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2.7 Gene expression and protein purification
Wild-type E2 (E2-WT) and mutant proteins were produced in E. coli strain BL21(DE3) follow-
ing a previously describedprotocol.[38] The E. coli cells were cultured in LB medium supple-
mented with 100 μg/ml ampicillin. Gene expression was induced by addition of 1 mM IPTG at
an optical density (OD600) between 0.6 and 0.8. Cells were harvested 3 h after induction by cen-
trifugation at 4500 ×g for 40 min and stored at -80°C. Subsequently, the cells were suspended
in HEPES buffer (25 mMHEPES, pH 8.0) and disrupted by ultra-sonication. The supernatant
after centrifugation at 40000 ×g for 1 h was heat-treated at 72°C for 20 min to denature the
majority of E. coli proteins. Re-centrifugation at 40000 ×g for 1 h was then used to remove the
denatured proteins.
The supernatant after ultra-centrifugationwas filtered and loaded onto an anion exchange
chromatography column (HiPrep Q 16/10 Q FF, GE Healthcare), which had been equilibrated
with HEPES buffer (pH 8.0) on an ÄKTA liquid chromatography system (GE Healthcare). The
E2 protein was eluted with HEPES buffer containing 1 M NaCl at elution concentration gradi-
ent set over 5 column volumes. Fractions containing the pure E2 protein were pooled. The con-
centration of protein was determinedwith a Micro BCA protein assay kit (Pierce) using bovine
serum albumin (BSA) as the standard.
2.8 Determinationof the self-assembly state of E2 protein cages
The self-assembly of mutant E2 protein cages in 20 mMTris pH 8.7 was characterised by
dynamic light scattering (DLS) (Zetasizer nano ZS, Malvern, UK). DLS was used to assess the
hydrodynamic diameters of the proteins (1 mg/ml) at 25°C with 5 min equilibration. Results
were an average of 3 measurements.
2.9 Internalisationof Ni-NTA-functionalised peptide coated gold
nanoparticles into E2 protein cages
All protein cages were washed twice in milliQ water on Nanosep 10 kDa filters and dispersed
in 50 mMNaH2PO4, 0.5 M NaCl pH 8.0 (phosphate buffer). Final concentrations of the cages
were about 1 μM.
In 500 μL centrifuge tubes, 50 μL H-CVVVT-ol:HS-(CH2)11-EG4:HS-(CH2)11-EG3-NTA
60:30:10 (mole/mole/mole) coated gold nanoparticles (3.9 nm) at 0.4 μM were mixed with
50 μL of E2 protein cages at 1 μM overnight at room temperature. Samples were then stored at
4°C for a few days and analysed by electronmicroscopy.
2.10 High-resolution transmission electronmicroscopy analysis
Gold nanoparticles were concentrated by ultrafiltration of stock solutions with Nanosep 30
kDa filters. Concentrated solutions were deposited on Ultrathin Carbon (< 3 nm) on Carbon
Table 1. Oligonucleotides for plasmid construction.
Protein cage code Oligonucleotide for plasmid constructiona
E2-LH2 C GAA AAG CCG ATC GTT CGT CAT CAT GAA ATC GTT GCT GCT CCG AT
E2-LH5 C GAA AAG CCG ATC GTT CAT CAT CAT CAT CAT ATC GTT GCT GCT CCG AT
E2-LH6 C GAA AAG CCG ATC GTT CAT CAT CAT CAT CAT CAT ATC GTT GCT GCT CCG AT
E2-H3LH3 AAG CCG ATC GTT CAT CAT CAT CGT GAC GGT GAA CAT CAT CAT ATC GTT GCT GCT
aMutation and insertionsites are in bold.
doi:10.1371/journal.pone.0162848.t001
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Holey support film TEM grids (Ultrathin Carbon / Holey Support on 400 mesh, Pelco Inter-
national, USA). Gold nanoparticles and protein cages were analysed with a Philips CM300
high resolution analytical TEM/STEM. Typically, protein cage mixtures were analysed at 0.1
mg/mL stained with 1% (w/v) sodium phosphotungstate tribasic hydrate. Obtained images
were not digitally modified, such as, for example, to remove the carbon grids. The size deter-
mination of the gold nanoparticles was done with ImageJ v1.47e software using the macro
‘ParticleSizeAnalyzer’.
Results and Discussion
3.1 Method for internalisationof gold nanoparticles into engineered
porous protein cages
We used the E2 protein, the core unit of the pyruvate dehydrogenase multi-enzyme complex
found in Geobacillus stearothermophilus as the porous protein cage model. The E2 protein cage
consists of 60 identical subunits self-assembled into a dodecahedralprotein complex.[38] The
three-dimensional crystal structure of the E2 protein cage shows that it forms a cage-like struc-
ture of 25 nm in diameter and with 12 pores of 6 nm across (Fig 1). Because of its structural
and physical properties, the E2 protein cage is an interesting template for various biological
and chemical applications, and has been used as a platform for drug encapsulation[6,39] and
therapeutic applications.[40,41]
The method proposed here is developed in three steps (Fig 2). We first introduced onto the
inner surface of the protein cages oligohistidine sequences of various lengths by site-directed
mutagenesis (Fig 2A).We chose to modify the E2 protein RDGE loop exposed in the cage’s core.
To impart the affinity for the oligohistidine sequences present inside the E2 protein cage’s core,
we passivated the surface of small gold nanoparticles with a SAM coating functionalisedwith Ni-
NTA moieties (Fig 2B). The specific internalisation of coated gold nanoparticles inside mutated
E2 protein cages (Fig 2C) was thenmonitored and evaluated by electronmicroscopy.
3.2 E2 protein cage platforms engineeredwith oligohistidine sequences
In this investigation, we considered two major factors that would drive the successful internali-
sation of small gold nanoparticles functionalisedwith Ni-NTA groups into oligohistidine
Fig 1. The E2 porous protein cage. (A) and (B) E2 protein cage three-dimensional structure (adapted from
PDB ID: 1b5s).[42] The inserts show typical electronmicroscopy images of the 5-fold axis (A) and 2-fold axis
(B) orientationsof the protein cage E2. The diameterD of the E2 protein cage is 25 nm. The diameterd of
each pore is 6 nm. (C) E2 protein cage inner surface presentingRDGE loop sequences in blue. The diameter
δ of the cage core is 13 nm.
doi:10.1371/journal.pone.0162848.g001
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mutated E2 protein cages: the stability of the protein cages and the binding strength between
the oligohistidine sequences and the Ni-NTA groups.
We studied the formation of modifiedE2 protein cages presenting various oligohistidine
sequences on the protein cages’ inner surface. To ensure the correct self-assembly and stability
of the protein cages while providing sufficient access to the oligohistidine sequences, we chose
to modify the RDGE loop present on the inner surface of the E2 protein cages. We synthesised
four different variants of the E2 protein cage, i.e., E2-LH2, E2-LH5, E2-LH6 and E2-H3LH3,
presenting an increasing number of histidine residues at the RDGE loop sequence by substitu-
tion and/or addition of histidine residues (Table 2). We evaluated each design for their ability
to form stable protein cage self-assemblies and providing sufficient bonding strength between
the oligohistidine sequences and the Ni-NTA groups to retain gold nanoparticles in their core.
The E2-LH2 protein cage was modified the least and the length of the polypeptide backbone in
the loop was unchanged, and therefore it was considered to have the least effect on the cage for-
mation and might potentially possess sufficient affinity to retain Ni-NTA functionalised
Fig 2. Method for specific internalisation of peptide coatedgold nanoparticles into engineered E2
protein cages. (a) Site-directedmutagenesis of E2 protein cage’s core with oligohistidine sequences (blue)
at the RDGE loop (green) on E2 protein subunits; (b) Surface coating of 3.9 nm gold nanoparticles with a self-
assembledmonolayer made of peptidols and thiolated alkane ethylene glycol (EG) ligands, functionalised
with Ni2+ nitrilotriacetic moieties (NTA, Ni2+); (c) Specific internalisation by affinity binding of Ni-NTA-
functionalised peptide coated gold nanoparticles into E2 protein cages presenting oligohistidine sequences.
doi:10.1371/journal.pone.0162848.g002
Table 2. Dynamic light scattering analysis of wild-typeand engineered E2 protein cageswith differentoligohistidine sequencesat the RDGE loop.
Protein cage code Protein sequence Size (nm) peak 1a Size (nm) peak 2a
E2-WT . . . P377IVRDGEIVA386. . . 25.0 ± 0.6 -
E2-LH2 . . . P377IVRHHEIVA386. . . 25.3 ± 0.8 -
E2-LH5 . . .P377IVHHHHHIVA387. . . 26.1 ± 0.9 -
E2-LH6 . . .P377IVHHHHHHIVA388. . . 28.1 ± 1.2 -
E2-H3LH3 . . .P377IVHHHRDGEHHHIVA392. . . 24.3 ± 2.4 12.5 ± 0.8
aAverages of the size distribution by volume, obtained from threemeasurements for each protein cage.
doi:10.1371/journal.pone.0162848.t002
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nanoparticles. In the case of the E2-LH5 protein cage, the polypeptide loop is longer by one
amino acid and so it might affect the cage formation. Moreover, the five consecutive histidine’s
side chains may also affect cage formation by driving unanticipated protein-protein interac-
tions. This mutant was also more likely, compared to the E2-LH2 protein cage, to possess near
full affinity similar to that of the standard hexa-histidine used in molecular biology/biotechnol-
ogy. In fact, Knecht et al. demonstrated that oligohistidine sequences greater than four histi-
dines provide highest binding affinity to Ni-NTA groups compared to smaller oligomers.[43]
The E2-LH6 protein cage would possess full affinity to Ni-NTA groups, but would also have
the greatest potential to affect the cage formation, since it had an increased length of the poly-
peptide backbone in the loop by two residues and the six consecutive histidine’s side chains
may have some effect on the cage formation by driving unanticipated protein-protein interac-
tions. Lastly, the E2-H3LH3 protein cage has the largest insert, with the histidines flanking the
loop amino acids, which are retained. Splitting the hexa-histidine sequence with the core of the
endogenous loop amino acids enabled to gain insight into the potential of histidine tracts of
four or more in the loop to disrupt cage formation. Thus, this mutant allowed testing the idea
that (within limits) the size of the loop can be substantially increased, but that four or more
consecutive histidine residues (as in E2-LH5 and E2-LH6) are disruptive to cage formation.
The correct formation and stability of the E2 protein cage mutants was confirmed by
dynamic light scattering (DLS) measurement (Table 2) and by transmission electronmicros-
copy (TEM) (Fig 3). The DLS size measurements showed that the introduction of bis-histidine
(E2-LH2) and penta-histidine (E2-LH5) sequences per E2 protein subunit did not interfere
with the correct formation of the E2 protein cages. However, the introduction of a hexa-histi-
dine sequence resulted in a slightly increased size and the protein cages presented some insta-
bility during storage. The mutant E2-H3LH3 did not form a correctly assembled protein cages
and was excluded from subsequent experiments. Hence, the results indicated that consecutive
tracts of histidines are likely to be tolerated and that the size of the loop is probably the most
important parameter to consider for the correct formation of stable protein cages.
Fig 3. Electronmicroscopy of wild-typeand engineered E2 protein cages. Images of the E2 protein cages: (A, E)
E2-WT; (B, F) E2-LH2; (C, G) E2-LH5; (D, H) E2-LH6. (A–D) scale bars are 100 nm. (E–H) scale bars are 50 nm.
doi:10.1371/journal.pone.0162848.g003
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3.3 Ni-NTA-functionalised peptide coated gold nanoparticles
Gold nanoparticles of 3.9 nm in diameter (Fig 4A) were coated with multiple Ni-NTA groups.
The preparation of NTA-functionalised peptide coated gold nanoparticles was done by passiv-
ation of citrate gold nanoparticles surface with a SAM consisting of a mixture of a peptidol
H-CVVVT-ol and a thiolated alkane ethylene glycol ligand HS-(CH2)11-EG4 at a 60:30 ratio
(mol:mol). The utilisation of such SAM has previously been shown to increase the stability
[37,44] and facilitate the biofunctionalisation of gold nanoparticles.[36,45] An analogous SAM
of pentapeptides have been shown to add 1.2 nm to the hydrodynamic radius of the nanoparti-
cles.[46] NTA moieties were introduced to the monolayer by adding 10% (mol:mol) of the
ligand HS-(CH2)11-EG3-NTA. The NTA-functionalised peptide coated gold nanoparticles
were then loaded with Ni2+ for binding of the nanoparticles to oligohistidine sequences present
on the inner surface of the protein cages. The functionalisationwith HS-(CH2)11-EG3-NTA
ligands and the specific binding to a oligohistidine tagged biomaterial were evaluated by the
immobilisation of Ni-NTA-functionalised peptide coated gold nanoparticles on a hexa-histi-
dine loaded agarose resin. All the Ni-NTA-functionalised peptide coated gold nanoparticles
bound to the oligohistidine tagged resin, showing that 100% of the gold nanoparticles were
functionalisedwith NTA moieties and activated with the Ni2+ (Fig 4C). Moreover, the experi-
ment confirmed that in the absence of Ni2+ loading, the NTA-functionalised SAM coated gold
nanoparticles did not present any non-specific binding to biomaterials (Fig 4B). This result
corroborated some previously reported experiments where such SAM coated noble metal
nanoparticles showed no non-specific binding to biomolecules and live cells.[37,44,45,47]
3.4 Peptide coated gold nanoparticles internalised into E2 protein cages
The internalisation of small Ni-NTA-functionalised gold nanoparticles into E2 protein cages
was compared between the three mutated E2 protein cages, E2-LH2, E2-LH5 and E2-LH6,
with the wild-type E2 protein cage as the control. The Ni-NTA-functionalised gold nanoparti-
cles and the protein cages were washed in phosphate buffer at pH 8 and mixed with E2 protein
cages at room temperature overnight. Each preparation was then analysed by TEM. The TEM
Fig 4. Ni-NTA-functionalised peptidecoated gold nanoparticles. (A) Size distribution of 212 gold
nanoparticles with an average diameter of 3.9 ± 0.8 nm. The insert shows a typical electronmicroscopy
image used for size measurement. Immobilisation of Ni-NTA-functionalised peptide coated gold
nanoparticles on a hexa-histidine loaded resin. (B) NTA-functionalised SAM coated gold nanoparticlesnot
loadedwith Ni2+ present no non-specific binding to hexa-histidine resin. (C) 10% (mol:mol) Ni-NTA-
functionalised peptide coated gold nanoparticles fully bind to hexa-histidine resin as no free gold
nanoparticles are found in the clear supernatant.
doi:10.1371/journal.pone.0162848.g004
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images showed that for the E2-WT (Fig 5A) and the E2-LH2 (Fig 5B) there was no evidence
for internalisation of the nanoparticles into the cages. In contrast, protein cages presenting lon-
ger oligohistidine sequences at their inner surface, i.e., E2-LH5 and E2-LH6, enabled the inter-
nalisation and immobilisation of Ni-NTA-functionalised gold nanoparticles. This was
evidencedby the presence of multiple instances of gold nanoparticles perfectly aligned into the
centre of the protein cages (white circles in Fig 5C and 5D). Such instances were not encoun-
tered in any analysis done with E2-WT or E2-LH2 protein cages. Hence a sequence of five or
six histidines is needed to allow for the internalisation and subsequent immobilisation of Ni-
NTA-functionalised gold nanoparticles. This result corroborates other studies that showed a
greater binding strength between penta- and hexa-histidine sequences and Ni-NTA moieties
compared to shorter oligohistidine sequences.[43] In addition, based on TEM, no obvious dif-
ference in the hybrid nanoparticle formation was observedbetween the E2-LH5 and E2-LH6
cages. Moreover, we also envisaged that the gold nanoparticles could potentially block the
pores and remain in that position. In such case, more than one gold nanoparticle could attach
to the protein cage at each of the 12 available pores. Based on TEM data, the binding of the
gold nanoparticles was inside the lumen of the E2 protein cage (E2-LH5 and E2-LH6) and not
at the pores. Also, since the pores are approximately 6 nm in diameter, we expected that only
Ni-NTA-functionalised gold nanoparticles with sizes equal to or smaller than the pores will
gain entry to the lumen. In addition, the lumen is only 13 nm and the longest distance of 8 nm
Fig 5. Transmission electronmicroscopy of samples of Ni-NTA-functionalised gold nanoparticles and
E2 protein cages.Ni-NTA-functionalised gold nanoparticles mixed with (A) E2-WT, (B) E2-LH2, (C) E2-LH5,
(D) E2-LH6.White circles indicate Ni-NTA-functionalised gold nanoparticles internalised into oligohistidine
modifiedE2 protein cages. The samples were stainedwith 1% (w/v) phosphotungstic acid. Scale bars are
100 nm.
doi:10.1371/journal.pone.0162848.g005
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between the loops.[48] Hence, as expected, we observed that only one nanoparticle can be
encapsulated in each E2 protein cage. The number of hybrid nanoparticles observedby TEM
seemed relatively low. This may be explained by the size of the coated gold nanoparticles used
in this study that was close to the cage pores diameter of nearly 6 nm. Reduction of the diame-
ter of the nanoparticles or the thickness of the ligand shell may be necessary to improve the
internalisation efficiency and the purification of the hybrid nanoparticles from the excess of
gold nanoparticles and empty protein cages (S1–S3 Figs) may be required for the further char-
acterization and utilisation of the hybrid nanoparticles in various applications.
Conclusions
We demonstrated the engineering of three novel porous E2 protein cages, i.e., E2-LH2,
E2-LH5, E2-LH6, modified by site-directedmutagenesis and exposing bis-, penta- and hexa-
histidine sequence into their core. Furthermore, the preparation of small Ni-NTA-functiona-
lised gold nanoparticles passivated with a self-assembledmonolayer of short peptidols and
thiolated alkane ethylene glycol ligands allowed for their specific binding to hexa-histidine
loaded agarose gels. The investigation of the combination of oligohistidine-modifiedporous E2
protein cages with Ni-NTA-functionalised peptide coated gold nanoparticles helped draw
important conclusions on the feasibility of a direct and specific internalisation of inorganic
nanoparticles into mutated E2 protein cages via affinity binding through the pores of the pro-
tein cages. The internalised gold nanoparticle will provide additional functionalities to the pro-
tein cage for future diagnostic development.
Supporting Information
S1 Fig. Purification of mixture of 3.9 nm diameter Ni2+ NTA-functionalised gold nanopar-
ticles and 25 nm diameter Dyelight650 tagged E2-WTprotein cages by size-exclusion chro-
matography.
(PDF)
S2 Fig. Purification of mixture of 3.9 nm diameter Ni2+ NTA-functionalised gold nanopar-
ticles and 25 nm diameter E2-LH5 protein cages by size-exclusion chromatography.
(PDF)
S3 Fig. Electronmicroscopy analysis of (A-B) the fraction 4 and (C-D) the fraction 6 after
purification of mixture of 3.9 nm diameterNi2+ NTA-functionalised gold nanoparticlesand
25 nm diameter E2-LH5 protein cages by Superdex 200 size-exclusion chromatography.
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